Such as histopathology or clinical chemistry prescription drugs side effects.

Discovery of biomarkers for early detection of pre – preclinical drug-induced nephrotoxicityCompugen Ltd. announced the discovery and experimental validation a novel combination of four biomarkers for early detection of drug-induced nephrotoxicity. Data indicate that the enable biomarker signature can a much earlier prediction of drug-induced renal toxicity in preclinical studies in rats as compared to conventional diagnostic methods, such as histopathology or clinical chemistry prescription drugs side effects .

About Drug-induced nephrotoxicityCurrent tools for the diagnosis of renal function include blood tests, such as blood urea nitrogen and serum creatinine levels, the significant results show only after substantial kidney injury has occurred, the pharmaceutical industry spends significant amounts. Of money, time and effort to detect toxic drug effects as early as possible to prevent the progress of such drug candidates into more expensive drug development stages. Since the kidney is one of the primary sites of drug toxicity, early detection of nephrotocxicity in the preclinical phase of drug development is a major unmet need.

NIMS , an with ISO 13485 certified company, is well licenses to sell Exer residual Canada, the European Common Market and other important markets in the world. Exer moiety is regulated as a Class IIa a medical device with CE certification outside the U.S.

Other articles from category "myology":

Random articles